|
Mechanismβ1-adrenergic receptor antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.DE |
First Approval Date01 Jan 1997 |
Blutzucker-Nachtprofile Mit Wecker Und Selbstmessungen gegenüber Fremdmessungen Durch Spezialisiertes Pflegepersonal: Eine Analyse Mittels Kontinuierlichem Glukose-Monitoring (Glucoday®)
Study hypothesis: Waking up in response to an alarm clock may evoke a stress reaction that leads to rising glucose concentrations.
The purpose of this study was to prove this hypothesis with continuous glucose monitoring over three nights.
Night (a) with an alarm clock set at 2 h intervals for glucose self monitoring,
Night (b) with a nurse performing blood glucose determinations, and
Night (c) with the patients left undisturbed.
Effects of NEbivolol on Subclinical Left Ventricular dYSfunction. A Comparative Study Against Metoprolol. The ENESYS Study. A Phase 3, Randomised, Parallel, Active-controlled, Open Label Study
Summary:
Study title: Effects of Nebivolol on subclinical left ventricular dysfunction. A comparative study against Metoprolol. (ENESYS study)
Study phase: 3
Study design (parallel, cross-over, etc.), randomisation and blinding procedures, type of control (placebo or active): randomised, parallel, active-controlled, open label
Study treatment(s)/drug(s): Nebivolol versus Metoprolol
Patients:
characteristics: patients with hypertension and left ventricular hypertrophy
planned total number: 50
Study duration:
total enrolment period (months): 18
treatment period (months): 6
follow up period (months): 6
Total study duration (months): 24
Number of Centres: 1
Country(ies): Romania (RO)
Intervention Project of Cerebrovascular Diseases and Dementia in the District of Ebersberg
In Western Countries, stroke and dementia are the main causes of long-term disability, dependency, and nursing home admission. Due to demographic trends a continuous increase of patient numbers can be expected.
There is growing evidence that vascular risk factors which are implicated in the etiology of stroke also play important etiologic roles in both vascular dementia and Alzheimer disease. The present project is aimed at the reduction of stroke and dementia by means of a systematic detection and subsequent treatment of vascular risk factors by the family doctor based on established guidelines.
100 Clinical Results associated with Berlin-Chemie/Menarini Pharma GmbH
0 Patents (Medical) associated with Berlin-Chemie/Menarini Pharma GmbH
100 Deals associated with Berlin-Chemie/Menarini Pharma GmbH
100 Translational Medicine associated with Berlin-Chemie/Menarini Pharma GmbH